{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:48:00Z","timestamp":1790804880799,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014679","name":"CRUK and EPSRC Cancer Imaging Centre in Cambridge and Manchester","doi-asserted-by":"publisher","award":["C8742"],"award-info":[{"award-number":["C8742"]}],"id":[{"id":"10.13039\/501100014679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Desorption electrospray ionisation mass spectrometry (DESI-MS) can image hundreds of molecules in a 2D tissue section, making it an ideal tool for mapping tumour heterogeneity. Tumour lipid metabolism has gained increasing attention over the past decade; and here, lipid heterogeneity has been visualised in a glioblastoma xenograft tumour using 3D DESI-MS imaging. The use of an automatic slide loader automates 3D imaging for high\u00a0sample-throughput. Glioblastomas are highly aggressive primary brain tumours, which display heterogeneous characteristics and are resistant to chemotherapy and radiotherapy. It is therefore important to understand biochemical contributions to their heterogeneity, which may be contributing to treatment resistance. Adjacent sections to those used for DESI-MS imaging were used for H&amp;E staining and immunofluorescence to identify different histological regions, and areas of hypoxia. Comparing DESI-MS imaging with biological staining allowed association of different lipid species with hypoxic and viable tissue within the tumour, and hence mapping of molecularly different tumour regions in 3D space. This work highlights that lipids are playing an important role in the heterogeneity of this xenograft tumour model, and DESI-MS imaging can be used for lipid 3D imaging in an automated fashion to reveal heterogeneity, which is not apparent in H&amp;E stains alone.<\/jats:p>","DOI":"10.1038\/s41598-020-73518-x","type":"journal-article","created":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T10:05:05Z","timestamp":1601892305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["3D DESI-MS lipid imaging in a xenograft model of glioblastoma: a proof of principle"],"prefix":"10.1038","volume":"10","author":[{"given":"Fiona","family":"Henderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emrys","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Denbigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidan","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmy","family":"Hoyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Claude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaye J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Roncaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,5]]},"reference":[{"key":"73518_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis, D. N. et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131, 803\u2013820 (2016).","journal-title":"Acta Neuropathol."},{"key":"73518_CR2","first-page":"1","volume":"5","author":"A Soeda","year":"2015","unstructured":"Soeda, A. et al. The evidence of glioblastoma heterogeneity. Sci. Rep. 5, 1\u20137 (2015).","journal-title":"Sci. Rep."},{"key":"73518_CR3","doi-asserted-by":"publisher","first-page":"22477","DOI":"10.1038\/srep22477","volume":"6","author":"NR Parker","year":"2016","unstructured":"Parker, N. R. et al. Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma. Sci. Rep. 6, 22477 (2016).","journal-title":"Sci. Rep."},{"key":"73518_CR4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/neuonc\/nov031","volume":"17","author":"MD Prados","year":"2015","unstructured":"Prados, M. D. et al. Toward precision medicine in glioblastoma: the promise and the challenges. Neuro-Oncol. 17, 1051\u20131063 (2015).","journal-title":"Neuro-Oncol."},{"key":"73518_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/nbm.1419","volume":"23","author":"NK Srivastava","year":"2010","unstructured":"Srivastava, N. K., Pradhan, S., Gowda, G. A. & Kumar, R. In vitro, high-resolution 1H and 31P NMR based analysis of the lipid components in the tissue, serum, and CSF of the patients with primary brain tumors: one possible diagnostic view. NMR Biomed. 23, 113\u2013122 (2010).","journal-title":"NMR Biomed."},{"key":"73518_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/bip.10005","volume":"62","author":"V Tugnoli","year":"2001","unstructured":"Tugnoli, V. et al. Characterization of lipids from human brain tissues by multinuclear magnetic resonance spectroscopy. Biopolymers 62, 297\u2013306 (2001).","journal-title":"Biopolymers"},{"key":"73518_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/cas.12108","volume":"104","author":"YJ Zhang","year":"2013","unstructured":"Zhang, Y. J., Wang, H., Zhang, J., Lv, J. W. & Huang, Y. R. Positive feedback loop and synergistic effects between hypoxia-inducible factor-2 and stearoylCoA desaturase-1 promote tumorigenesis in clear cell renal cell carcinoma. Cancer Sci. 104, 416\u2013422 (2013).","journal-title":"Cancer Sci."},{"key":"73518_CR8","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1158\/0008-5472.CAN-07-2489","volume":"68","author":"E Furuta","year":"2008","unstructured":"Furuta, E. et al. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res. 68, 1003\u20131011 (2008).","journal-title":"Cancer Res."},{"key":"73518_CR9","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/sj.bjc.6603350","volume":"95","author":"W Zhao","year":"2006","unstructured":"Zhao, W. et al. Fatty acid synthase: a novel target for antiglioma therapy. Br. J. Cancer 95, 869\u2013878 (2006).","journal-title":"Br. J. Cancer"},{"key":"73518_CR10","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1158\/1078-0432.CCR-07-4177","volume":"14","author":"H Orita","year":"2008","unstructured":"Orita, H., Coulter, J., Tully, E., Kuhajda, F. P. & Gabrielson, E. Inhibiting fatty acid synthase for chemoprevention of chemically induced lung tumors. Clin. Cancer Res. 14, 2458\u20132464 (2008).","journal-title":"Clin. Cancer Res."},{"key":"73518_CR11","first-page":"707","volume":"1","author":"S Rossi","year":"2003","unstructured":"Rossi, S. et al. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol. Cancer Res. 1, 707\u2013715 (2003).","journal-title":"Mol. Cancer Res."},{"key":"73518_CR12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jocn.2012.03.050","volume":"20","author":"BB Tao","year":"2013","unstructured":"Tao, B. B. et al. Up-regulation of USP2a and FASN in gliomas correlates strongly with glioma grade. J. Clin. Neurosci. 20, 717\u2013720 (2013).","journal-title":"J. Clin. Neurosci."},{"key":"73518_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1088\/0031-9155\/58\/2\/187","volume":"58","author":"JMY Willaime","year":"2013","unstructured":"Willaime, J. M. Y., Turkheimer, F. E., Kenny, L. M. & Aboagye, E. O. Quantification of intra-tumour cell proliferation heterogeneity using imaging descriptors of 18F fluorothymidine-positron emission tomography. Phys. Med. Biol. 58, 187\u2013203 (2013).","journal-title":"Phys. Med. Biol."},{"key":"73518_CR14","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.2967\/jnumed.108.053397","volume":"49","author":"JF Eary","year":"2008","unstructured":"Eary, J. F., O\u2019Sullivan, F., O\u2019Sullivan, J. & Conrad, E. U. Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome. J. Nucl. Med. 49, 1973\u20131979 (2008).","journal-title":"J. Nucl. Med."},{"key":"73518_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ejca.2011.12.025","volume":"48","author":"MC Asselin","year":"2012","unstructured":"Asselin, M. C., O\u2019Connor, J. P. B., Boellaard, R., Thacker, N. A. & Jackson, A. Quantifying heterogeneity in human tumours using MRI and PET. Eur. J. Cancer 48, 447\u2013455 (2012).","journal-title":"Eur. J. Cancer"},{"key":"73518_CR16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1126\/science.1104404","volume":"306","author":"Z Takats","year":"2004","unstructured":"Takats, Z., Wiseman, J. M., Gologan, B. & Cooks, R. G. Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science 306, 471\u2013473 (2004).","journal-title":"Science"},{"key":"73518_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1039\/C4AY01770F","volume":"7","author":"N Abbassi-Ghadi","year":"2015","unstructured":"Abbassi-Ghadi, N. et al. Repeatability and reproducibility of desorption electrospray ionization-mass spectrometry (DESI-MS) for the imaging analysis of human cancer tissue: a gateway for clinical applications. Anal. Methods 7, 71\u201380 (2015).","journal-title":"Anal. Methods"},{"key":"73518_CR18","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1073\/pnas.1700677114","volume":"114","author":"S Banerjee","year":"2017","unstructured":"Banerjee, S. et al. Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids. Proc. Natl. Acad. Sci. USA 114, 3334\u20133339 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73518_CR19","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jasms.2009.01.017","volume":"20","author":"RB Chen","year":"2009","unstructured":"Chen, R. B., Hui, L. M., Sturm, R. M. & Li, L. J. Three dimensional mapping of neuropeptides and lipids in crustacean brain by mass spectral imaging. J. Am. Soc. Mass Spectrom. 20, 1068\u20131077 (2009).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"73518_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"S Giordano","year":"2016","unstructured":"Giordano, S. et al. 3D mass spectrometry imaging reveals a very heterogeneous drug distribution in tumors. Sci. Rep. 6, 1\u20138 (2016).","journal-title":"Sci. Rep."},{"key":"73518_CR21","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/anie.200906283","volume":"49","author":"LS Eberlin","year":"2010","unstructured":"Eberlin, L. S., Ifa, D. R., Wu, C. & Cooks, R. G. Three-dimensional vizualization of mouse brain by lipid analysis using ambient ionization mass spectrometry. Angewandte Chemie-International Edition 49, 873\u2013876 (2010).","journal-title":"Angewandte Chemie-International Edition"},{"key":"73518_CR22","doi-asserted-by":"publisher","first-page":"35374","DOI":"10.1038\/srep35374","volume":"6","author":"A Tata","year":"2016","unstructured":"Tata, A. et al. Rapid detection of necrosis in breast cancer with desorption electrospray ionization mass spectrometry. Sci. Rep. 6, 35374 (2016).","journal-title":"Sci. Rep."},{"key":"73518_CR23","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1073\/pnas.1523306113","volume":"113","author":"AK Jarmusch","year":"2016","unstructured":"Jarmusch, A. K. et al. Lipid and metabolite profiles of human brain tumors by desorption electrospray ionization-MS. Proc. Natl. Acad. Sci. USA 113, 1486\u20131491 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73518_CR24","doi-asserted-by":"publisher","first-page":"5623","DOI":"10.1007\/s00216-016-9665-y","volume":"408","author":"B Jayashree","year":"2016","unstructured":"Jayashree, B. et al. Monitoring of changes in lipid profiles during PLK1 knockdown in cancer cells using DESI MS. Anal. Bioanal. Chem. 408, 5623\u20135632 (2016).","journal-title":"Anal. Bioanal. Chem."},{"key":"73518_CR25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1158\/0008-5472.CAN-11-2465","volume":"72","author":"LS Eberlin","year":"2012","unstructured":"Eberlin, L. S. et al. Classifying human brain tumors by lipid imaging with mass spectrometry. Cancer Res. 72, 645\u2013654 (2012).","journal-title":"Cancer Res."},{"key":"73518_CR26","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1073\/pnas.1215687110","volume":"110","author":"LS Eberlin","year":"2013","unstructured":"Eberlin, L. S. et al. Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors. Proc. Natl. Acad. Sci. USA 110, 1611\u20131616 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73518_CR27","doi-asserted-by":"publisher","first-page":"D527","DOI":"10.1093\/nar\/gkl838","volume":"35","author":"M Sud","year":"2007","unstructured":"Sud, M. et al. LMSD: LIPID MAPS structure database. Nucleic Acids Res. 35, D527\u2013D532 (2007).","journal-title":"Nucleic Acids Res."},{"key":"73518_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1194\/jlr.M027961","volume":"54","author":"K Chughtai","year":"2013","unstructured":"Chughtai, K., Jiang, L., Greenwood, T. R., Glunde, K. & Heeren, R. M. Mass spectrometry images acylcarnitines, phosphatidylcholines, and sphingomyelin in MDA-MB-231 breast tumor models. J. Lipid Res. 54, 333\u2013344 (2013).","journal-title":"J. Lipid Res."},{"key":"73518_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/neuonc\/now128","volume":"19","author":"H Lin","year":"2016","unstructured":"Lin, H. et al. Fatty acid oxidation is required for the respiration and proliferation of malignant glioma cells. Neuro Oncol. 19, 43\u201354 (2016).","journal-title":"Neuro Oncol."},{"key":"73518_CR30","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/j.celrep.2014.08.028","volume":"8","author":"D Huang","year":"2014","unstructured":"Huang, D. et al. HIF-1-mediated suppression of Acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression. Cell Rep. 8, 1930\u20131942 (2014).","journal-title":"Cell Rep."},{"key":"73518_CR31","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1101\/gad.1987211","volume":"25","author":"K Zaugg","year":"2011","unstructured":"Zaugg, K. et al. Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev. 25, 1041\u20131051 (2011).","journal-title":"Genes Dev."},{"key":"73518_CR32","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3390\/cancers12051213","volume":"12","author":"A Bronisz","year":"2020","unstructured":"Bronisz, A., Salinska, E., Chiocca, E. A. & Godlewski, J. Hypoxic roadmap of glioblastoma-learning about directions and distances in the brain tumor environment. Cancers 12, 1213 (2020).","journal-title":"Cancers"},{"key":"73518_CR33","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/neuonc\/now258","volume":"19","author":"N Colwell","year":"2017","unstructured":"Colwell, N. et al. Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells. Neuro-Oncol. 19, 887\u2013896 (2017).","journal-title":"Neuro-Oncol."},{"key":"73518_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/cells6040045","volume":"6","author":"AR Monteiro","year":"2017","unstructured":"Monteiro, A. R., Hill, R., Pilkington, G. J. & Madureira, P. A. The role of hypoxia in glioblastoma invasion. Cells 6, 45 (2017).","journal-title":"Cells"},{"key":"73518_CR35","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/neuonc\/nou035","volume":"16","author":"A Vartanian","year":"2014","unstructured":"Vartanian, A. et al. GBM\u2019s multifaceted landscape: highlighting regional and microenvironmental heterogeneity. Neuro-Oncol. 16, 1167\u20131175 (2014).","journal-title":"Neuro-Oncol."},{"key":"73518_CR36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73518-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73518-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73518-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:13:01Z","timestamp":1670357581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73518-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["73518"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-73518-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,5]]},"assertion":[{"value":"6 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16512"}}